Abiopharma

🔍 FRANCISCO PARTNERS IV, L.P. (Executive)

Company: GoodRx Holdings, Inc. (GDRX)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Acquired 4,995,903 shares of Class A Common Stock (Direct)
  Date: 2026-08-19 | Code: C | equity_swap_involved: false | shares_owned_after: 4,995,903.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2
• Acquired 2,504,097 shares of Class A Common Stock (Direct)
  Date: 2026-08-19 | Code: C | equity_swap_involved: false | shares_owned_after: 2,504,097.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2
• Sold 3,596,648 shares of Class A Common Stock (Direct)
  Date: 2026-08-19 | Code: J | equity_swap_involved: false | shares_owned_after: 1,399,255.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Sold 1,142,357 shares of Class A Common Stock (Direct)
  Date: 2026-08-19 | Code: J | equity_swap_involved: false | shares_owned_after: 1,361,740.00 | transaction_form_type: 4 | Footnotes: F4, F2
• Sold 237,671 shares of Class A Common Stock at $3.5299 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 1,161,584.00 | transaction_form_type: 4 | Footnotes: F5, F2
• Sold 234,304 shares of Class A Common Stock at $3.5299 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 1,127,436.00 | transaction_form_type: 4 | Footnotes: F5, F2
• Sold 233,415 shares of Class A Common Stock at $3.5205 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: false | shares_owned_after: 928,169.00 | transaction_form_type: 4 | Footnotes: F6, F2
• Sold 213,844 shares of Class A Common Stock at $3.5205 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: false | shares_owned_after: 913,592.00 | transaction_form_type: 4 | Footnotes: F6, F2
• Sold 138,338 shares of Class A Common Stock at $3.4968 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 789,831.00 | transaction_form_type: 4 | Footnotes: F7, F2
• Sold 136,379 shares of Class A Common Stock at $3.4968 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 777,213.00 | transaction_form_type: 4 | Footnotes: F7, F2
• Sold 4,995,903 shares of Class B Common Stock (Derivative)
  Date: 2026-08-19 | Code: C | equity_swap_involved: false | shares_owned_after: 35,023,391.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F2
• Sold 2,504,097 shares of Class B Common Stock (Derivative)
  Date: 2026-08-19 | Code: C | equity_swap_involved: false | shares_owned_after: 17,554,793.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F2

Footnotes:

• F1: Represents the conversion of Class B Common Stock ("Class B Shares") into shares of Class A Common Stock (the "Class A Shares") on a one-for-one basis.
• F2: Francisco Partners GP IV, L.P. is the general partner of each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Francisco Partners GP IV Management Limited is the general partner of Francisco Partners GP IV, L.P. Francisco Partners Management, L.P. serves as the investment manager for each of Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. Voting and disposition decisions at Francisco Partners Management, L.P. with respect to the shares of Class B common stock held by Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. are made by an investment committee. Each of Francisco Partners Management, L.P., Francisco Partners GP IV Management Limited, and Francisco Partners GP IV, L.P. may be deemed to share voting and dispositive power over the shares of Class B common stock held, but disclaims beneficial ownership.
• F3: Francisco Partners IV, L.P. made a pro rata distribution of 3,596,648 shares of Class A Shares to its general partner and limited partners for no consideration on August 19, 2026.
• F4: Francisco Partners IV-A, L.P. made a pro rata distribution of 1,142,357 shares of Class A Shares to its general partner and limited partners for no consideration on August 19, 2026.
• F5: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/19/2026 at prices ranging from $3.465 to $3.59 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F6: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/20/2026 at prices ranging from $3.465 to $3.59 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F7: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions on 8/21/2026 at prices ranging from $3.445 to $3.565 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.